We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Urology

Journal Scan / Research · July 13, 2021

Efficacy and Adverse Events Following Treatment With Fesoterodine for OAB

Neurourology and Urodynamics


Additional Info

Disclosure statements are available on the authors' profiles:

Neurourology and Urodynamics
What Are the Chances of Improvement or Cure From Overactive Bladder? A Pooled Responder Analysis of Efficacy and Treatment Emergent Adverse Events Following Treatment With Fesoterodine
Neurourol Urodyn 2021 May 26;[EPub Ahead of Print], AS Wagg, S Herschorn, M Carlsson, M Fernet, M Oelke

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading